https://www.zonebourse.com/cours/action/TRANSGENE-4789/actualite/Transgene-Premier-patient-traite-dans-un-nouvel-essai-clinique-de-TG6002-un-virus-oncolytique-de-30033319/?utm_source=telegram&utm_medium=social&utm_campaign=share